Aphria

Aphria Equity

Delisted

The The Equity of Aphria (APHA.TO) as of Oct 21, 2026 is 1.81 B CAD. In the previous year, The Equity was 1.70 B CAD — a change of 6.32% (higher).

Equity

1.81 BCAD

YoY

6.32%

Last updated:

In 2020, Aphria's equity was 1.81 B CAD, a 6.32% increase from the 1.70 B CAD equity in the previous year.

The Aphria Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2015
13.35 M CAD
Jan 1, 2016
35.01 M CAD
Jan 1, 2017
273.87 M CAD
Jan 1, 2018
1.16 B CAD
Jan 1, 2019
1.70 B CAD
Jan 1, 2020
1.81 B CAD
The Aphria Equity history
YEAREquityYoY
1.81 BCAD+6.32%
1.70 BCAD+46.45%
1.16 BCAD+325.03%
273.87 MCAD+682.18%
35.01 MCAD+162.36%
13.35 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aphria Stock analysis

What does Aphria do? Aphria Inc is a Canadian company in the cannabis industry. It was founded in 2013 and is headquartered in Leamington, Ontario, Canada. The company originally started as Medical Marijuana Inc but changed its name to Aphria Inc in 2015. Aphria produces and sells medical and recreational cannabis in Canada and other countries worldwide. They focus on research and development to ensure their products meet the highest standards. The company has different divisions, including Aphria Medical, Broken Coast Cannabis, and Tanout Farms, which produce various cannabis products for medical and recreational use. Some of the products they offer include different strains of cannabis plants, cannabis oil, and premium cannabis varieties. Aphria aims to cater to different target audiences and provide a comprehensive range of products in the cannabis market. Aphria is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Aphria's Equity

Aphria's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aphria's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Aphria's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Aphria's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Aphria’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Aphria stock

The Equity of Aphria is 1.81 B CAD in 2020.

The Equity of Aphria changed from 1.70 B CAD to 1.81 B CAD, representing a 6.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Aphria since 2006 – with annual values, charts, and detailed analysis.

The Equity's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Aphria historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Aphria

All Key Metrics — Aphria